Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis

Journal of Asthma

Volumn 50, Issue 9, 2013, Pages 960-964

  Li, Ping ^a   Zhao, Guo Qiang ^b   Chen, Teng Fei ^a   Chang, Jing Xia ^a   Wang, Hua Qi ^a   Chen, Shan Shan ^a   Zhang, Guo Jun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Idiopathic pulmonary fibrosis; MiRNA 155; MiRNA 21; QRT PCR; Serum

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 155; MICRORNA 21;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENE EXPRESSION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SAMPLE;

ADULT; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STATISTICS, NONPARAMETRIC; VITAL CAPACITY;

EID: 84885933752     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.822080     Document Type: Article

References (33)

1. Spruit MA, Janssen DJ, Franssen FM, Wouters EF. Rehabilitation and palliative care in lung fibrosis. Respirology 2009;14:781-787
2. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011;6: E28486
3. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer: A survey. Biochim Biophys Acta 2007;1775:181-232
4. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-10518
5. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-854
6. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, et al. Detection of elevated levels of tumourassociated microRNAs in serum of patients with diffuse large Bcell lymphoma. Br J Haematol 2008;141:672-675
7. Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C. Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 2012;41:1897-1912
8. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011;108: 3713-3718
9. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. MiR-1254 and miR-574-5p: Serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011;6: 482-488
10. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, Kosuga T, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011;105:104-111
11. Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, et al. Global microRNA expression profiling of micro dissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer 2012;131: E86-E95
12. Jusufović E, Rijavec M, Keser D, Korošec P, Sodja E, Iljazović E, Radojević Z, Košnik M. Let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survivaloutcomes in non-small-cell lung cancer. PLoS One 2012;7:e45577
13. Wang Y, Rathinam R, Walch A, Alahari SK. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 2009;284:23094-23106
14. Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, et al. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One 2011;6:e16979
15. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010;207: 1589-1597
16. Schmittgen TD, Livak KJ. Analyzing real-Time PCR data by the comparative C (T) method. Nat Protoc 2008;3:1101-1108
17. Ge TT, Liang Y, Fu R, Wang GJ, Ruan EB, Qu W, Wang XM, et al. Expressions of miR-21, miR-155 and miR-210 in plasma of patients with lymphoma and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012;20:305-309
18. Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012;58:610-618
19. Sun Y, Wang M, Lin G, Sun S, Li X, Qi J, Li J. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One 2012;7:e47003
20. Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012;29:618-626
21. Cai EH, Gao YX, Wei ZZ, Chen WY, Yu P, Li K. Serum miR-21 expression in human esophageal squamous cell carcinomas. Asian Pac J Cancer Prev 2012;13:1563-1567
22. Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011;50:136-142
23. Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW, Wong YN, et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012;61:739-745
24. Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, Hua M, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-g. Nat Immunol 2011;12:861-869
25. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, et al. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 2009;200:916-925
26. Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 2011;104:847-851
27. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009;55:1944-1949
28. Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, Wang Y, et al. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 2012; 8:811-818
29. Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: Implication in epithelial-mesenchymal interactions. PLoS One 2009;4:e6718
30. Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: A typical multifunctional microRNA. Biochim Biophys Acta 2009; 1792:497-505
31. Behr J. Idiopathic pulmonary fibrosis: Modern guideline-concordant diagnostics and innovative treatment. Dtsch Med Wochenschr 2012;137:601-604
32. Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Müller N, Schwartz DA, King Jr. TE, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003;124:1215-1223
33. Raghu G, Collard HR, Eqan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183: 788-824